Education
About Us
Working with TipRanks
Follow Us
Emergent Biosolutions (EBS)
NYSE:EBS
Earnings Data
Report Date
Nov 05, 2025TBA (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
0Last Year’s EPS
1.37Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call presented a positive outlook overall, with significant financial improvements, better-than-expected revenue and EBITDA, and strategic growth in international markets. Despite some declines in specific product sales, the company demonstrated resilience and adaptability in its core operations.Company Guidance -
Q3 2025
Revenue and EBITDA Exceed Expectations
Second quarter revenues of $141 million exceeded the guidance range of $95 million to $120 million by $21 million. Adjusted EBITDA for the second quarter was $29 million, an increase of $39 million compared to negative $10 million the prior year.
Improved Financial Position
Year-to-date liquidity increased by $297 million, with an access to $367 million for growth opportunities. Net leverage improved significantly to 1.9x debt-to-adjusted EBITDA, down from 9.9x in the second quarter of 2024.
NARCAN Sales Rebound
NARCAN sales saw a 50% increase in revenue in the second quarter as compared to the first quarter of 2025, following a one-time disruption.
Inclusion in Russell 3000 Index
Emergent's stock rebounded to qualify for inclusion in the Russell 3000 Index, showcasing improved market sentiment and financial health.
MCM International Sales Growth
International medical countermeasure sales represent 40% of year-to-date revenues, highlighting strong performance and strategic focus on global markets.
EBS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
EBS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 06, 2025 | $6.03 | $8.24 | +36.65% |
May 07, 2025 | $4.74 | $6.36 | +34.18% |
Mar 03, 2025 | $6.83 | $6.39 | -6.44% |
Nov 06, 2024 | $9.20 | $11.00 | +19.57% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Emergent Biosolutions (EBS) report earnings?
Emergent Biosolutions (EBS) is schdueled to report earning on Nov 05, 2025, TBA (Confirmed).
What is Emergent Biosolutions (EBS) earnings time?
Emergent Biosolutions (EBS) earnings time is at Nov 05, 2025, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is EBS EPS forecast?
EBS EPS forecast for the fiscal quarter 2025 (Q3) is 0.